Bastianelli Enrico

All filings by Bastianelli Enrico on record concern Egeiro Pharma. In total, 2 filings cover trades dated from 28 March 2022 to 21 November 2023.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 2 February 2024: a transaction of €380k, in Egeiro Pharma. These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.